Quick Answer
PLUS THERAPEUTICS, INC. reported Total Assets of $16.32 million for fiscal year 2025.
PLUS THERAPEUTICS, INC. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $16.32M | +146.1% |
| 2024 | $6.63M | -41.8% |
| 2023 | $11.39M | -52.3% |
| 2022 | $23.87M | +8.6% |
| 2021 | $21.98M | +81.6% |
| 2020 | $12.11M | -47.9% |
| 2019 | $23.23M | -3.2% |
| 2018 | $23.99M | -24.1% |
| 2017 | $31.61M | -8.7% |
| 2016 | $34.61M | -8.2% |
| 2015 | $37.70M | -2.6% |
| 2014 | $38.72M | -7.9% |
| 2013 | $42.06M | -2.8% |
| 2012 | $43.25M | -16.1% |
| 2011 | $51.53M | -22.3% |
| 2010 | $66.35M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $18.67M | +167.6% | +80.4% |
| June 30, 2025 | $10.35M | -7.7% | -14.2% |
| March 31, 2025 | $12.06M | +114.5% | +81.8% |
| December 31, 2024 | $6.63M | -41.8% | -4.9% |
| September 30, 2024 | $6.98M | -47.4% | -37.8% |
| June 30, 2024 | $11.21M | -21.0% | +99.5% |
| March 31, 2024 | $5.62M | -64.1% | -50.6% |
| December 31, 2023 | $11.39M | -52.3% | -14.2% |
- PLUS THERAPEUTICS, INC. showed an increase of +146.1% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, PLUS THERAPEUTICS, INC.’s total assets has declined by 75.4% (from $66.35 million to $16.32 million).
- The most recent figure is from PLUS THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: